Apontis Pharma AG (APPH.DE)
EUR 10.05
(0.0%)
EUR 10.05
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -20.8 Million EUR | 42.77% |
| 2022 | -36.34 Million EUR | -21.8% |
| 2021 | -29.84 Million EUR | -270.28% |
| 2020 | -8.05 Million EUR | -9.1% |
| 2019 | -7.38 Million EUR | 18.06% |
| 2018 | -9.01 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -16.15 Million EUR | 22.33% |
| 2023 Q4 | -20.8 Million EUR | 20.92% |
| 2023 FY | -20.8 Million EUR | 42.77% |
| 2023 Q2 | -26.3 Million EUR | 27.63% |
| 2022 Q2 | -32.22 Million EUR | -7.99% |
| 2022 FY | -36.34 Million EUR | -21.8% |
| 2022 Q4 | -36.34 Million EUR | -12.79% |
| 2021 FY | -29.84 Million EUR | -270.28% |
| 2021 Q4 | -29.84 Million EUR | 2.2% |
| 2021 Q2 | -30.51 Million EUR | -278.62% |
| 2020 Q4 | -8.05 Million EUR | 0.0% |
| 2020 FY | -8.05 Million EUR | -9.1% |
| 2019 FY | -7.38 Million EUR | 18.06% |
| 2018 FY | -9.01 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| MPH Health Care AG | 8.5 Million EUR | 344.633% |
| Dermapharm Holding SE | 921.66 Million EUR | 102.257% |
| Evotec SE | 115.28 Million EUR | 118.042% |
| MERCK Kommanditgesellschaft auf Aktien | 7.95 Billion EUR | 100.261% |
| PharmaSGP Holding SE | 33.21 Million EUR | 162.63% |
| SynBiotic SE | 3.59 Million EUR | 679.219% |